Search

Researchers at Mapua University in Manila, Philippines, have conducted a study on the pharmacological potential and electrochemical characteristics of Typha angustifolia (TA) pollen, traditionally used in Chinese medicine. The study aimed to evaluate the antiviral properties of TA by analyzing its antioxidant activity and bioenergy-generating capabilities. Results showed that the water extract of TA exhibited higher antioxidant activity compared to the ethanol extract, with specific electron-shuttling compounds identified. The research suggests that TA pollen has potential bioenergy-generating and antiviral properties, which could lead to the development of targeted antiviral medications with reduced toxicity and costs. [Extracted from the article]

A patent application titled "Therapeutic And Preventive Compositions" discusses the use of bee-derived components and marine plasma in creating compositions for antimicrobial use. The application highlights the potential benefits of utilizing bee-derived materials, such as zabrus, honey, royal jelly, and pollen, in combination with seawater for therapeutic purposes. The invention aims to provide methods and compositions that can prevent, ease, or relieve symptoms of viral, bacterial, fungal, or parasitic infections in humans or animals with minimal side effects and reduced risk of resistance development. The patent application emphasizes the importance of prophylactic approaches to combat infectious diseases and mentions specific antiviral defense mechanisms in bees. [Extracted from the article]

A recent consumer study found that a natural complex called Plasys300 by Pharmactive Biotech Products, S.L.U. may help alleviate nocturia, a common issue in men with an enlarged prostate. The product, made from rye pollen enriched with phytosterols, was shown to reduce nighttime urination and improve overall quality of life in participants. Plasys300 works by balancing hormones and relaxing the urinary tract, offering a potential natural solution for men's urinary health. [Extracted from the article]

Researchers at Shandong Normal University conducted a study on the effects of pine pollen polysaccharides and sulfated polysaccharides on ulcerative colitis in mice by regulating Th17/Treg balance. The study found that these compounds could alleviate ulcerative colitis by reducing liver Treg cells, rebalancing Th17/Treg, and modulating inflammatory cytokines. Additionally, the compounds were shown to impact gut bacteria composition and metabolite distribution, with sulfated polysaccharides exhibiting better anti-colitis activity. This research provides valuable insights into potential treatments for ulcerative colitis. [Extracted from the article]

A recent study conducted at Nanjing University in Jiangsu, China has discovered a new strategy for reprogramming tumor-associated macrophages (TAMs) to enhance lung cancer immunotherapy. The researchers developed inhalable bioorthogonal gene-editable microparticles that utilize spike-covered sunflower sporopollenin exine capsules (SECs) as delivery vehicles. These microparticles effectively reprogram TAMs by physically stimulating them, producing a Toll-like receptor 7 agonist, and employing CRISPR/Cas9 gene editing. In an orthotopic mouse model, the inhalation of these microparticles improved macrophage functionality and resulted in long-lasting anti-tumor effects. This research provides valuable insights into the development of more effective lung cancer treatments. [Extracted from the article]

A new study conducted by researchers at the Netherlands Organisation for Applied Scientific Research examines the simultaneous threshold exceedance of heat, air pollution, and airborne allergenic pollen in Europe. The study utilizes modelled data and health-based threshold values to assess the exposure to these environmental risk factors. The findings reveal that there are varying degrees of simultaneous threshold exceedance of air pollution and heat throughout Europe, with the Mediterranean area experiencing the highest levels. The research provides a robust approach that can guide policymakers in identifying high-risk areas and developing mitigation strategies. [Extracted from the article]

A comprehensive review conducted by the University of Fukui in Japan explores the pathogenesis, epidemiology, and treatment approaches of pollen-food allergy syndrome (PFAS). PFAS is caused by a cross-reaction between specific pollen antigens and corresponding food allergens in sensitized individuals. While symptoms are typically limited to oral manifestations, they can also include rhinitis, respiratory and skin symptoms, and anaphylactic shock. The prevalence of PFAS varies depending on geographic conditions, and effective treatment options are currently lacking. The review highlights the need for further research to improve outcomes for patients with PFAS. [Extracted from the article]

A recent study conducted by researchers at the Autonomous University of Nuevo Leon (UANL) in Mexico has found that vaginal ovules loaded with bismuth lipophilic nanoparticles (BisBAL NPs) and cetylpyridinium chloride (CPC) have antineoplastic and antimicrobial properties. The researchers developed a clinically viable dosage form for vaginal application and conducted various tests to assess the efficacy of the vaginal ovules. The results showed that the BisBAL NP-CPC vaginal ovules demonstrated antifungal efficacy comparable to miconazole and reduced the growth of cervical cancer cells. This innovative drug delivery system shows promise for topical antimycotic and anti-cervical carcinoma treatments. [Extracted from the article]

Researchers from the Department of Dermatology in Beijing, China have conducted a study on the use of recombinant Art V4.01 protein in immunotherapy for allergic asthma. Art V4.01 is a profilin protein commonly involved in triggering allergic asthma. The study found that the recombinant protein was effective in reducing the number of inflammatory cells, levels of pro-inflammatory cytokines, and serum IgE levels in a mouse model of allergic asthma. These findings suggest that Art V4.01 could be a potential candidate for allergen-specific immunotherapy. [Extracted from the article]

A recent study conducted by researchers at the University of Campinas in Brazil focused on the botany of the Aspidosperma Mart & Zucc. species of plants in the Apocynaceae family. The researchers investigated the anther wall and pollen development of five species of Aspidosperma and found that they exhibited fibrous endothecium, middle layer, and secretory tapetum with specific characteristics. The study suggests that these deposition patterns may be a shared characteristic among other genera within the Aspidospermateae tribe. This research provides valuable insights into the embryological characters of early diverging taxa in the Apocynaceae family. [Extracted from the article]

A recent study conducted by researchers from the Medical University of Vienna explores the use of adoptive cell therapy in mice sensitized to a grass pollen allergen. The researchers investigated whether cell therapy could modulate an established secondary allergen-specific immune response in pre-immunized mice. The study found that pre-existing secondary allergen-specific immune responses pose a significant challenge to tolerization through cell therapy, highlighting the importance of prophylactic approaches for preventing IgE-mediated allergies. This research provides valuable insights into the development of potential treatments for allergies. [Extracted from the article]

A clinical trial, NCT06459219, has been launched to study nasal allergen exposure in patients aged 60 and older with or without current respiratory allergies. The trial aims to understand the mechanism behind the development of tolerance to allergens in a subset of allergic patients with advanced age. The study will involve intranasal challenges with birch pollen extract and will assess clinical parameters, cytokines, allergen-specific Immunoglobulin (Ig) levels, and inflammatory cell subsets. The results of this study will provide valuable information for the development of new therapeutic approaches for respiratory allergies. [Extracted from the article]

A recent study conducted by researchers at Kohat University of Science and Technology in Pakistan explores the potential benefits of bee pollen as a food and feed supplement, as well as a therapeutic remedy. Bee pollen is a valuable product that contains numerous bioactive components and beneficial elements such as magnesium, calcium, manganese, potassium, and phenolic compounds. It possesses various properties, including antioxidant, anti-inflammatory, antimicrobial, antiviral, analgesic, immunostimulant, neuroprotective, anti-cancer, and hepatoprotective properties. The study highlights the potential apitherapeutic efficacy of bee pollen and its growing interest as a natural remedy and nutritive function. [Extracted from the article]

A group of scientists from Nagoya University in Japan have used a specialized microscopic technique to observe the internal reproduction process of the Arabidopsis plant. Their findings, published in EMBO Reports, reveal the mechanism behind a female flower selectively attracting a single male counterpart. This research provides valuable information about how plants reproduce and has the potential to benefit agricultural breeding by increasing seed production and improving germination rates. The study also discovered a repulsion signal emitted by the female tissue, which discourages the attraction of additional pollen tubes. [Extracted from the article]

A new study conducted at Victor Babes University of Medicine and Pharmacy in Timisoara, Romania, has found that a recombinant version of the major ragweed allergen Amb a 1.01 exhibits similar allergenic properties to its natural counterpart. Amb a 1 is responsible for over 90% of the IgE response in ragweed-allergic patients. The study aimed to produce a recombinant version of Amb a 1.01 for improved ragweed allergy management. The results showed that the recombinant protein had comparable IgE reactivity and allergenic activity to the natural isoform, providing a basis for improving ragweed allergy research, diagnosis, and immunotherapy. [Extracted from the article]

A study conducted by researchers at the Russian Academy of Sciences focuses on the structural and immunological features of PR-10 allergens, specifically the major alder pollen allergen Aln g 1. The study found that Aln g 1 has the ability to upregulate alarmins in epithelial cells, playing a role in sensitization. The researchers also discovered that by replacing two residues in the structure of Aln g 1, its ability to bind to IgE from allergic patients and lipid ligands decreased. This research opens up possibilities for the development of hypoallergenic variants of Aln g 1 for allergen-specific immunotherapy. [Extracted from the article]

Regeneron Pharmaceuticals Inc. has been granted a patent for a method of treating allergies using a combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation. The patent acknowledges the limitations of current allergy treatments and proposes a new therapeutic approach. The method involves administering the inhibitors and ablating agents to reduce or eliminate allergen-specific serum IgE in individuals with allergic diseases or disorders. The patent provides detailed information about the specific inhibitors and their administration, as well as potential additional therapeutic agents. The full patent, filed by Seblewongel Asrat and assigned to Regeneron Pharmaceuticals Inc., is available for further reference. [Extracted from the article]

A report from Monash University in Melbourne, Australia discusses research on sublingual immunotherapy (SLIT) for grass pollen allergy. The study found that SLIT can modify the natural history of allergic rhinitis and increase allergen-specific IgG(4) levels. The researchers used single-cell RNA sequencing to analyze B memory cell subsets before and after SLIT, and identified two unique subsets with different transcriptional profiles. The study suggests that changes in surface-expressed proteins on these subsets could serve as early biomarkers for treatment effects. [Extracted from the article]

A recent study conducted by researchers at Ningxia Medical University in China analyzed the mugwort pollen allergen Art v 1 protein using bioinformatics techniques. The researchers obtained the gene and amino acid sequences of the protein and used various tools to analyze its physicochemical properties, transmembrane region, secondary and tertiary structures, as well as predict B cell and Th cell epitopes. The study found that the Art v 1 protein has good antigenicity due to the presence of B cell and Th cell epitopes. This research provides valuable insights into the molecular characteristics of mugwort pollen allergens and their potential for immune system responses. [Extracted from the article]

A report from the Second Affiliated Hospital of Dalian Medical University in China discusses the relationship between air pollution and pollinosis, a common allergic disease. The research suggests that air pollution is a key environmental factor that contributes to the increased prevalence of pollinosis. Air pollutants and pollen allergens work together to stimulate allergic responses in susceptible individuals. The report analyzes the mechanisms by which air pollution increases the incidence of pollinosis and exacerbates allergic reactions. The researchers call for future studies to explore the effects of different types of pollutants on pollen and the response mechanisms of allergy-related cells and cytokines. This research aims to provide a comprehensive understanding of the impacts of air pollution on pollen allergies and scientific evidence for effective protection of pollinosis patients' health. [Extracted from the article]

A recent report from Sandro Pertini Hospital in Rome, Italy, discusses the prevalence and origins of IgE antibodies to cross-reactive carbohydrate determinants (CCD) in childhood allergies. The study found that IgE to CCD was present in 22% of Italian pollen allergic children, particularly those with an IgE response to grass pollen. These children also had higher total IgE levels and were sensitized to more allergenic molecules. The research suggests that group 1 and/or 4 allergen molecules of grass pollen may be major inducers of these antibodies. [Extracted from the article]

A new study conducted by a researcher at the College of Applied Medical Science in Hail, Saudi Arabia, has found that extracts from maize and clover pollen grains have potential antimicrobial, antioxidant, and anticancer activities. The study revealed that the clover pollen grains extract exhibited stronger antibacterial and antioxidant activities compared to the maize pollen grains extract. However, the maize pollen grains extract was more effective in inhibiting the growth of human colon cancer cells. These findings suggest that both types of pollen grains have potential therapeutic applications for the treatment of infectious diseases and malignancies. [Extracted from the article]

New research from Northwest University explores the therapeutic effects of peony pollen on primary dysmenorrhea in mice. The study found that peony pollen can attenuate uterus contractions and reduce pain and inflammation associated with primary dysmenorrhea. It also modulates oxidative stress and apoptosis by regulating the COX-2/PGE2 pathway. These findings suggest that peony pollen may be a potential treatment for primary dysmenorrhea. [Extracted from the article]

A recent study conducted by researchers at Juntendo University in Tokyo, Japan, has shed light on the mechanisms behind the development of allergic conjunctivitis. The study found that the instillation of pollen shells rapidly induces the formation of goblet cell-associated antigen passages (GAPs) in the conjunctiva, which play a role in the transport of allergens. The research also identified the sensory nervous system as playing an essential role in this process. These findings suggest that pollen shell-induced GAPs could be a potential therapeutic target for allergic conjunctivitis. [Extracted from the article]

A patent application titled "Treatment Protocol Using Intralymphatic Immunotherapy" has been published online. The inventors propose an improved treatment for allergic diseases using Intralymphatic Immunotherapy (ILIT). ILIT involves delivering medicine directly to the lymph node to change the immune response and relieve symptoms. The inventors suggest that a lower dosage of allergen combined with a lowered ratio of allergen to adjuvant could improve the efficacy and reduce side effects of ILIT. The patent application provides details on the composition and method for administering ILIT for grass allergy treatment. [Extracted from the article]

A study conducted at the University of Melbourne in Australia investigated the effects of bee pollen (BP) and doxorubicin (DOX) on breast tumor cells in a mouse model. The study found that BP, when used in combination with DOX, reduced tumor volume and increased the expression of apoptotic genes and proteins. Additionally, the combination treatment reduced levels of estrogen, nitric oxide, and pro-inflammatory cytokines, while increasing serum interferon-gamma levels. The study concluded that BP, with its synergistic effects along with DOX, has the ability to suppress tumor growth and inhibit oxidative damage caused by DOX. [Extracted from the article]

A patent application has been submitted for a pharmaceutical composition that aims to address the global issue of allergic diseases. The application discusses the mechanism of allergen immunotherapy and explores different methods of administration. It also emphasizes the need for improved safety in allergenic extracts and proposes the use of epinephrine to reduce reactions. The method described in the application involves administering a composition with a vasoconstrictor and allergen through intradermal administration, aiming to reduce allergic reactions and benefit patients at risk of developing allergies. The application provides details on dosage and types of allergens and vasoconstrictors that can be used. [Extracted from the article]

A recent study conducted by researchers at the University of Eastern Finland explores the relationship between pollen exposure and respiratory infections. The study found that exposure to pollen can increase the risk and severity of respiratory infections, but it may also have a protective function. The researchers conducted experiments using airway cells exposed to different types of pollen and viral or bacterial challenges. They discovered that pollen exposure weakened immune reactions to bacterial and viral challenges, while viral challenges elicited exaggerated immune responses against pollen. These findings suggest that pollen exposure during the pollen season could contribute to the acceleration and complication of infections. [Extracted from the article]

A recent study conducted by researchers at the University of Tokyo in Japan explored the effects of a specific acid, (+/-)5(6)-DiHETE, on allergic conjunctivitis (AC) using a mouse model. AC is a common eye disorder that can significantly impact a patient's quality of life. The study found that the administration of (+/-)5(6)-DiHETE inhibited pollen-induced symptoms, such as eyelid edema and tearing, and also suppressed mast cell degranulation and eosinophil infiltration. Additionally, the acid showed potential in alleviating histamine-induced manifestations and reducing itching. These findings suggest that (+/-)5(6)-DiHETE could be a novel treatment option for AC. [Extracted from the article]

A patent has been issued for a Chinese medicine composition that can treat side effects caused by BCG perfusion therapy for bladder cancer. The composition is made from a mixture of various plant extracts and is administered to patients experiencing side effects such as red and swollen bladder lining, hematuria, and poor appetite. The patent also mentions that bladder cancer can include various types such as urothelial carcinoma, squamous cell carcinoma, adenocarcinoma, sarcoma, or small cell carcinoma. [Extracted from the article]

Keywords: Albumins; Allergens; Allergic Conjunctivitis; Allergies; Allergy Research; Conjunctival Diseases and Conditions; Conjunctivitis; Connective Tissue Cells; Cytometry; Dietary Egg Proteins; Egg Proteins; Epithelial Cells; Eye Diseases and Conditions; Flowering Tops; Goblet Cells; Health and Medicine; Immune System Diseases and Conditions; Intestinal Mucosa; Juntendo University Research Promotion Center; Ophthalmology; Ovalbumin; Plant Germ Cells; Plant Structures; Pollen; Proteins; Pulmonology; Serpins; Stromal Cells EN Albumins Allergens Allergic Conjunctivitis Allergies Allergy Research Conjunctival Diseases and Conditions Conjunctivitis Connective Tissue Cells Cytometry Dietary Egg Proteins Egg Proteins Epithelial Cells Eye Diseases and Conditions Flowering Tops Goblet Cells Health and Medicine Immune System Diseases and Conditions Intestinal Mucosa Juntendo University Research Promotion Center Ophthalmology Ovalbumin Plant Germ Cells Plant Structures Pollen Proteins Pulmonology Serpins Stromal Cells 1889 1889 1 10/30/23 20231103 NES 231103 2023 NOV 3 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- When it comes to eye allergies, the transition from allergen contact to bothersome symptoms has always been quick, appearing within a span of a few minutes. The initial stage of allergic conjunctivitis involves the penetration of allergen through the epithelial cell layer (cells covering the outer surface of the body). [Extracted from the article]

Biomedicine, Flowering Tops, Health and Medicine, Plant Germ Cells, Pollen, Plant Structures Keywords: Biomedicine; Flowering Tops; Health and Medicine; Plant Germ Cells; Plant Structures; Pollen EN Biomedicine Flowering Tops Health and Medicine Plant Germ Cells Plant Structures Pollen 6224 6224 1 10/24/23 20231027 NES 231027 2023 OCT 27 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on biomedicine is now available. [Extracted from the article]

For more information on this research see: Contributions of the N-terminal Flanking Residues of an Antigenic Peptide From the Japanese Cedar Pollen Allergen Cry J 1 To the T-cell Activation By Hla-dp5. Keywords: Kanagawa; Japan; Asia; Allergens; Allergies; Flowering Tops; Genetics; Health and Medicine; Immune System Diseases and Conditions; Peptides; Plant Germ Cells; Plant Structures; Pollen; Pollen Allergens; Proteins; Proteomics EN Kanagawa Japan Asia Allergens Allergies Flowering Tops Genetics Health and Medicine Immune System Diseases and Conditions Peptides Plant Germ Cells Plant Structures Pollen Pollen Allergens Proteins Proteomics 714 714 1 10/16/23 20231020 NES 231020 2023 OCT 20 (NewsRx) -- By a News Reporter-Staff News Editor at Genomics & Genetics Weekly -- Research findings on Immune System Diseases and Conditions - Allergies are discussed in a new report. [Extracted from the article]

Keywords: Brno; Czech Republic; Europe; Flowering Tops; Plant Germ Cells; Plant Structures; Pollen; Veterinary Medicine EN Brno Czech Republic Europe Flowering Tops Plant Germ Cells Plant Structures Pollen Veterinary Medicine 95 95 1 10/16/23 20231016 NES 231016 2023 OCT 16 (NewsRx) -- By a News Reporter-Staff News Editor at Veterinary Week -- New research on Veterinary Medicine is the subject of a report. Keywords for this news article include: Brno, Europe, Pollen, Czech Republic, Flowering Tops, Plant Germ Cells, Plant Structures, Veterinary Medicine. [Extracted from the article]

Repeated topical application of pollen induced conjunctivitis, accompanied by eyelid edema and tearing in mice. Keywords: Allergic Conjunctivitis; Allergies; Allergy Research; Autacoids; Biogenic Monoamines; Biological Factors; Conjunctival Diseases and Conditions; Conjunctivitis; Ethylamines; Eye Diseases and Conditions; Flowering Tops; Health and Medicine; Histamine; Inflammation; Ophthalmology; Plant Germ Cells; Plant Structures; Pollen; Serotonin EN Allergic Conjunctivitis Allergies Allergy Research Autacoids Biogenic Monoamines Biological Factors Conjunctival Diseases and Conditions Conjunctivitis Ethylamines Eye Diseases and Conditions Flowering Tops Health and Medicine Histamine Inflammation Ophthalmology Plant Germ Cells Plant Structures Pollen Serotonin 6242 6242 1 10/09/23 20231013 NES 231013 2023 OCT 13 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators discuss new findings in allergic conjunctivitis. Allergic Conjunctivitis, Allergies, Allergy Research, Autacoids, Biogenic Monoamines, Biological Factors, Conjunctival Diseases and Conditions, Conjunctivitis, Ethylamines, Eye Diseases and Conditions, Flowering Tops, Health and Medicine, Histamine, Inflammation, Ophthalmology, Plant Germ Cells, Pollen, Serotonin, Plant Structures. [Extracted from the article]

Stigma fluorescence assays showed that pollen germination was normal, but less pollen entered the ovaries. Keywords: Agriculture; Flowering Tops; Plant Germ Cells; Plant Research; Plant Structures; Pollen EN Agriculture Flowering Tops Plant Germ Cells Plant Research Plant Structures Pollen 4027 4027 1 09/11/23 20230915 NES 230915 2023 SEP 15 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on plant research are presented in a new report. Agriculture, Flowering Tops, Plant Germ Cells, Plant Research, Pollen, Plant Structures. [Extracted from the article]

Keywords: Munich; Germany; Europe; Actinobacteria; Allergies; Allergy Research; Antigen-Presenting Cells; Bifidobacterium; Blood Cells; Bone Marrow Cells; Cell Research; Cytokines; Dendritic Cells; Flowering Tops; Gram-Positive Asporogenous Rods; Gram-Positive Bacteria; Gram-Positive Rods; Health and Medicine; Hemic and Immune Systems; Immune System Diseases and Conditions; Immunology; Intercellular Signaling Peptides and Proteins; Lactobacillaceae; Lactobacillales; Lactobacillus; Monocytes; Mononuclear Leukocytes; Mononuclear Phagocyte System; Myeloid Cells; Phagocytes; Plant Germ Cells; Plant Structures; Pollen EN Munich Germany Europe Actinobacteria Allergies Allergy Research Antigen-Presenting Cells Bifidobacterium Blood Cells Bone Marrow Cells Cell Research Cytokines Dendritic Cells Flowering Tops Gram-Positive Asporogenous Rods Gram-Positive Bacteria Gram-Positive Rods Health and Medicine Hemic and Immune Systems Immune System Diseases and Conditions Immunology Intercellular Signaling Peptides and Proteins Lactobacillaceae Lactobacillales Lactobacillus Monocytes Mononuclear Leukocytes Mononuclear Phagocyte System Myeloid Cells Phagocytes Plant Germ Cells Plant Structures Pollen 4882 4882 1 09/11/23 20230915 NES 230915 2023 SEP 15 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on Gram-Positive Bacteria - Bifidobacterium is now available. For more information on this research see: Ex Vivo Immunomodulatory Effects of Lactobacillus-, Lacticaseibacillus-, and Bifidobacterium-containing Synbiotics On Human Peripheral Blood Mononuclear Cells and Monocyte-derived Dendritic Cells In the Context of Grass Pollen Allergy. [Extracted from the article]

Keywords: Tlalnepantla; Mexico; North and Central America; Botany; Life Sciences; Flowering Tops; Plant Germ Cells; Plant Structures; Pollen EN Tlalnepantla Mexico North and Central America Botany Life Sciences Flowering Tops Plant Germ Cells Plant Structures Pollen 2906 2906 1 08/21/23 20230825 NES 230825 2023 AUG 25 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on Life Sciences - Botany are presented in a new report. Keywords for this news article include: Tlalnepantla, Mexico, North and Central America, Botany, Life Sciences, Flowering Tops, Plant Germ Cells, Plant Structures, Pollen, National Autonomous University of Mexico (UNAM). The ontogeny of the anther wall, microsporogenesis, microgametogenesis, and pollen morphology were described in detail for Fouquieria fasciculata.". [Extracted from the article]

Keywords: Biotechnology; CRISPR; Flowering Tops; Gene Editing; Genetics; Genome Editing; Plant Germ Cells; Plant Structures; Pollen; Risk and Prevention; Stem Cell Research; Whitehead Institute for Biomedical Research EN Biotechnology CRISPR Flowering Tops Gene Editing Genetics Genome Editing Plant Germ Cells Plant Structures Pollen Risk and Prevention Stem Cell Research Whitehead Institute for Biomedical Research 2473 2473 1 07/03/23 20230704 NES 230704 2023 JUL 7 (NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- Humans split away from our closest animal relatives, chimpanzees, and formed our own branch on the evolutionary tree about seven million years ago. The researchers used CRISPRi to turn off each gene one at a time in a group of human stem cells and a group of chimp stem cells. When the researchers' approach identified genes that cluster in the same processes, this suggested to them that their approach had worked and that the genes were likely involved in human and chimp evolution. [Extracted from the article]